Serono completed the first phase of their large scale MS Whole Genome association study by annoucning that scans of 100,000 SNPs (single nucleotide polymorphisms) from 1,600 subjects, half of whom having mutlple sclerosis, revealed 80 genes involved in the inflammatory and neuro-degenerative pathways the disease. The company hopes to complete scans of the remaining 500,000 SNPs by the end of next year.